EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Estimated T50 calciprotein crystallization test in patients undergoing hemodialysis: Osaka Dialysis Complication Study (ODCS)

Tetsuo Shoji, Daijiro Kabata, Yu Nagakura, Shinya Nakatani, Hideki Uedono, Yuki Nagata, Hisako Fujii, Katsuhito Mori, Yasuo Imanishi, Tomoaki Morioka, Masanori Emoto

Clinical and Experimental Nephrology · 2025

DOI: 10.1007/s10157-025-02735-3 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Tetsuo Shoji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan. te…. Hauptthemen laut MEDLINE: Renal Dialysis, Renal Insufficiency, Chronic, Calcinosis, Calcium Pyrophosphate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japanese Association of Dialysis Physicians, Kyowa Kirin Farmacéutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: T50 calciprotein crystallization test (serum calcification propensity, T50) is a blood test which assesses the resistance of the serum to calcification stress in vitro. Because of its limited availability in clinical practice of chronic kidney disease, we aimed to develop equations for estimated T50 (eT50). METHODS: This was an observational study in 1,651 hemodialysis patients whose T50 was measured by the method Pasch et al. The data sets were divided into two groups for the derivation (N = 1,003) and validation (N = 648) of the equations. Logarithmically transformed values of measured T50 were regressed by relevant variables selected from 36 candidates based on the Akaike's Information Criteria. RESULTS: Because the initial model A included 19 variables, we developed simpler models B and C with 10 and 5 variables, respectively, for clinical use. All these models included serum phosphate, magnesium, sodium, chloride, and total ion binding capacity. When these equations were validated, the intercept, slope, and R2 values were 1.130, 0.770, 0.596 for model A, 1.093, 0.782, and 0.597 for model B, and 0.979, 0.806, and 0.573 for model C, respectively. Multivariable-adjusted Fine-Gray analysis showed that a lower eT50 value by model A, B, or model C was an independent predictor of a higher risk of new cardiovascular events in the total cohort as the measured T50 was. CONCLUSIONS: We developed three equations for eT50 from clinically available variables. These eT50 values may be useful if measured T50 is not available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisRenal Insufficiency, ChronicCalcinosisCalcium PyrophosphateHumansMaleFemaleMiddle AgedAgedCrystallizationPredictive Value of TestsReproducibility of Results

Stichwörter der Autor:innen

CalcificationCalciprotein particle (CPP)Cardiovascular diseaseCohortHemodialysis

Substanzen

Calcium Pyrophosphate

Autor:innen und Institutionen

  • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan. tetsuoshoji@omu.ac.jp.
  • Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan. tetsuoshoji@omu.ac.jp.
  • Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan. tetsuoshoji@omu.ac.jp.
  • Clinical Research Center, Aijinkai Inoue Hospital, Suita, 564-0053, Japan. tetsuoshoji@omu.ac.jp.
  • Center for Mathematical and Data Sciences, Kobe University, Kobe, 657-8501, Japan.
  • Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japanese Association of Dialysis Physicians
  • Kyowa Kirin Farmacéutica

Zitieren

APA

Shoji, T., Kabata, D., Nagakura, Y., Nakatani, S., Uedono, H., Nagata, Y., Fujii, H., Mori, K., Imanishi, Y., Morioka, T., & Emoto, M. (2025). Estimated T50 calciprotein crystallization test in patients undergoing hemodialysis: Osaka Dialysis Complication Study (ODCS). Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-025-02735-3

Vancouver

Shoji T, Kabata D, Nagakura Y, Nakatani S, Uedono H, Nagata Y, et al. Estimated T50 calciprotein crystallization test in patients undergoing hemodialysis: Osaka Dialysis Complication Study (ODCS). Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-025-02735-3

BibTeX
@article{Shoji2025,
  author = {Shoji, Tetsuo and Kabata, Daijiro and Nagakura, Yu and Nakatani, Shinya and Uedono, Hideki and Nagata, Yuki and Fujii, Hisako and Mori, Katsuhito and Imanishi, Yasuo and Morioka, Tomoaki and Emoto, Masanori},
  title = {Estimated T50 calciprotein crystallization test in patients undergoing hemodialysis: Osaka Dialysis Complication Study (ODCS)},
  journal = {Clinical and Experimental Nephrology},
  year = {2025},
  doi = {10.1007/s10157-025-02735-3}
}
Kostenlos starten →